PharmaPrimes provides advanced bioanalytical services supporting pharmaceutical and biopharmaceutical development programs.
Our laboratories provide regulatory-focused bioanalysis for small molecules, peptides, monoclonal antibodies, therapeutic proteins, and other biologics.
Our integrated services support preclinical studies, clinical trials, bioequivalence studies, and biosimilar development programs.
Supporting:
Customized bioanalytical method development for challenging drug molecules and complex biological matrices.
PharmaPrimes has documented experience with challenging metabolic drugs and GLP-1 analogues, including:
Bioanalytical methods are validated according to applicable ICH M10 Bioanalytical Method Validation requirements.
Integrated clinical and bioanalytical support for BE/BA studies and pharmacokinetic evaluation.
Analytical characterization, purity and heterogeneity assessment, glycosylation profiling, biological activity, process-related impurity testing, clinical PK, and immunogenicity support.
Hospital-based clinical research through the PharmaPrimes Clinical Research Center located within Jordan Hospital in Amman.
Tell us about your molecule, matrix, and study design, and our bioanalytical scientists will propose a method development and validation approach.
